Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) Return on Capital Employed (2016 - 2021)

GT Biopharma (GTBP) has disclosed Return on Capital Employed for 10 consecutive years, with 0.89% as the latest value for Q3 2021.

  • On a quarterly basis, Return on Capital Employed rose 788.0% to 0.89% in Q3 2021 year-over-year; TTM through Sep 2021 was 0.89%, a 788.0% increase, with the full-year FY2020 number at 0.21%, changed N/A from a year prior.
  • Return on Capital Employed was 0.89% for Q3 2021 at GT Biopharma, down from 0.86% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 44.04% in Q3 2019 to a low of 27.68% in Q2 2019.
  • A 5-year average of 3.23% and a median of 0.97% in 2017 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: soared 4602bps in 2019, then crashed -5281bps in 2020.
  • GT Biopharma's Return on Capital Employed stood at 0.54% in 2017, then plummeted by -270bps to 1.98% in 2018, then plummeted by -549bps to 12.86% in 2019, then surged by 98bps to 0.21% in 2020, then plummeted by -320bps to 0.89% in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Return on Capital Employed are 0.89% (Q3 2021), 0.86% (Q2 2021), and 1.79% (Q1 2021).